Skip to content

Improving Weight Loss in Healthy Adults With Overweight and Obesity: An Artificial Intelligence-assisted Dietary Prediction and Prevention System With Continuous Glucose Monitoring

Improving Weight Loss in Healthy Adults With Overweight and Obesity: An Artificial Intelligence-assisted Dietary Prediction and Prevention System With Continuous Glucose Monitoring

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07395466
Enrollment
300
Registered
2026-02-09
Start date
2025-01-22
Completion date
2026-07-01
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Overweight and/or Obesity, Overweight , Obesity, Overweight or Obese Adults

Brief summary

This study aims to examine the effectiveness of a novel dietary lapse prediction and prevention self-regulation app called the eating behaviour trigger-response inhibition program (eTRIP), and the addition of continuous glucose monitoring (CGM), on healthy eating and weight loss in people with overweight and obesity.

Interventions

BEHAVIORALeTRIP

Intervention group 1 involves using the eating behaviour trigger-response inhibition program(eTRIP) smartphone application for 10 weeks, where participants will need to take pictures of their food items as part of their food logging and may also engage with app-based activities to build self-regulatory skills in sticking to their weight loss plans. Additionally, participants will also apply a continuous glucose monitoring (CGM) sensor on their arm and taught how to scan the CGM sensor so that they can monitor their glucose levels for the first 10 days.

OTHERFatSecret

Intervention group 2 involves using the FatSecret smartphone application for participants to monitor their calorie intake, without any continuous glucose monitoring.

Sponsors

National University Health System, Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. are 21-65 years old 2. have BMI ≥23 kg/m2 3. can comprehend the English language 4. uses a smartphone that can download apps 5. are willing to perform continuous glucose monitoring (CGM) using the Dexcom continuous glucose monitoring system 6. willing to travel to the National University of Singapore (NUS) 7. able to provide informed consent

Exclusion criteria

1. are using/intend to use other apps for weight loss; 2. are pregnant or lactating (as it would affect weight change and caloric needs) 3. are diagnosed severe mental disorders (e.g. major depressive disorder and schizophrenia) 4. are on prescribed meal replacements or pharmacotherapy 5. have serious medical conditions 6. are scheduled for any kind of surgery within the next 6 months

Design outcomes

Primary

MeasureTime frameDescription
HeightAt weeks 0, 10 and 24.Taken using a wall mounted measuring tape.
WeightAt weeks 0, 10 and 24.Taken using InBody 120
Waist CircumferenceAt weeks 0, 10 and 24.Taken using a measuring tape.
BMIAt weeks 0, 10 and 24.Taken using InBody 120
Self regulation of Eating Behaviour Questionnaire (SREBQ)At weeks 0, 10 and 24.The Self-Regulation of Eating Behaviour Questionnaire (SREBQ) is a validated self-administered instrument used to assess individuals' self-regulation in relation to eating behavior. It evaluates the extent to which individuals monitor, control, and regulate their eating behaviors in everyday contexts. Higher scores indicate greater self-regulation of eating behavior.

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-2 (PHQ-2)At weeks 0, 10 and 24.The Patient Health Questionnaire - 2 item (PHQ-2) is a validated self-administered screening questionnaire used to assess the frequency of depressive symptoms over the past two weeks. Higher scores indicate greater depressive symptom severity.
Euro Quality of life 5 Dimensions-5 Levels (EQ-5D-5L)At weeks 0, 10 and 24.The EuroQol 5 Dimensions - 5 Levels (EQ-5D-5L) is a standardized self-administered instrument used to assess health-related quality of life. It measures five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with five response levels.
Generalized Anxiety Disorder 2-item (GAD-2)At weeks 0, 10 and 24.The Generalized Anxiety Disorder - 2 item (GAD-2) is a validated self-administered screening questionnaire used to assess the frequency of core anxiety symptoms over the past two weeks. Higher scores indicate greater anxiety symptom severity.
Percentage Body FatAt weeks 0, 10 and 24.Taken using InBody 120.
Body Fat MassAt weeks 0, 10 and 24.Taken using InBody 120.
Three Factor Eating Questionnaire (TFEQ)At weeks 0, 10 and 24.The Three-Factor Eating Questionnaire (TFEQ) is a validated self-administered instrument used to assess eating-related behaviors. It measures three domains: cognitive restraint of eating, uncontrolled eating, and emotional eating. Higher scores indicate greater levels of the respective eating behavior.
International Physical Activity Questionnaire Short-Form (IPAQ-SF)At weeks 0, 10 and 24.The International Physical Activity Questionnaire - Short Form (IPAQ-SF) is a validated self-administered questionnaire used to assess self-reported physical activity levels. It captures the frequency and duration of walking, moderate-intensity activity, and vigorous-intensity activity performed over the past 7 days.
Self-Report Behavioural Automaticity Index (SRBAI)At weeks 0, 10 and 24.The Self-Report Behavioural Automaticity Index (SRBAI) is a validated self-administered questionnaire used to assess the automaticity of behavior. It evaluates the extent to which a behavior is performed automatically, with little conscious thought or deliberation. Higher scores indicate greater behavioral automaticity.
Consideration of Future Consequences Scale (CFCS-6)At weeks 0, 10 and 24.The Consideration of Future Consequences Scale - 6 item (CFCS-6) is a validated self-administered questionnaire used to assess the extent to which individuals consider the potential future outcomes of their current behaviors. It evaluates the degree to which individuals weigh immediate versus future consequences when making decisions. Higher scores indicate greater consideration of future consequences.
Skeletal Muscle MassAt weeks 0,10 and 24.Taken using InBody 120.
Visceral Fat LevelAt weeks 0, 10 and 24.Taken using InBody 120.
Big Five Inventory - 44 item (BFI-44)At weeks 0, 10 and 24.The Big Five Inventory - 44 item (BFI-44) is a validated self-administered questionnaire used to assess personality traits across five domains: openness, conscientiousness, extraversion, agreeableness, and neuroticism. Higher scores indicate greater expression of the respective personality traits.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026